Third Point — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
The company develops a 6-base sequencing platform (duet evoC) that simultaneously profiles methylation (5mC, 5hmC), genetic variants, and fragmentomics from a single cfDNA sample.
BiotechDeep TechHealthtechCambridge
Jason Mellad(Executive Officer, Director)inMartin Murphy(Director)Bobby Yerramilli-Rao(Director)Somasundaram Subramaniam(Director)Timothy Rink(Director)Thomas Hulme(Director)
Co-investorsThird Point VenturesAhrenAhren Innovation CapitalGV (Google Ventures)New Science VenturesSequoia Capital+1 more
Menlo Park, US
David Jevans(Executive Officer, Director)
BoardAditya Singh(Director)Stephen Ryan(Director)
Co-investorsAcrew CapitalAspect VenturesNeotribe VenturesOwl CapitalThird Point VenturesWestWave Capital
Verbit is a voice AI platform providing transcription, captioning, translation, and audio description services through its Captivate technology.
AI & Machine LearningEnterprise SoftwareLegalTechSaaSTel Aviv, IL
Yair Amsterdam(CEO)in
Co-investorsAltaIR CapitalATOORO FUNDClaltechDisruptive AIHorizon CapitalOmega Venture Partners+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.